Search results

Evidence-based recommendations on raloxifene for the primary prevention of osteoporotic fragility fractures in postmenopausal women.

Result type

Technology appraisal guidance

Last updated

7 February 2018

Evidence-based recommendations on raloxifene and teriparatide for preventing osteoporotic fragility fractures in postmenopausal women who have osteoporosis.

Result type

Technology appraisal guidance

Last updated

7 February 2018

Evidence-based recommendations on radium-223 dichloride (Xofigo) for treating hormone-relapsed prostate cancer with bone metastases in adults.

Result type

Technology appraisal guidance

Published

28 September 2016

This guideline covers care and support for adults with cerebral palsy. It aims to improve health and wellbeing, promote access to services and support participation and independent living.

Result type

NICE guideline

Published

15 January 2019

Evidence-based recommendations on cetuximab (Erbitux), bevacizumab (Avastin) and panitumumab (Vectibix) for treating metastatic colorectal cancer in adults.

Result type

Technology appraisal guidance

Published

25 January 2012

Evidence-based recommendations on enzalutamide (Xtandi) for treating metastatic hormone-relapsed prostate cancer in adults who have had treatment with docetaxel-containing chemotherapy.

Result type

Technology appraisal guidance

Published

23 July 2014

Evidence-based recommendations on bevacizumab (Avastin), with gemcitabine and carboplatin, for treating platinum-sensitive advanced ovarian cancer in adults.

Result type

Technology appraisal guidance

Published

22 May 2013

Evidence-based recommendations on bevacizumab (Avastin), with paclitaxel and carboplatin, for treating advanced ovarian cancer in adults.

Result type

Technology appraisal guidance

Published

22 May 2013

Evidence-based recommendations on eribulin (Halaven) for treating locally advanced or metastatic (secondary) breast cancer in adults who have had only 1 course of chemotherapy.

Result type

Technology appraisal guidance

Published

28 March 2018

Evidence-based recommendations on lenvatinib (Lenvima) and sorafenib (Nexavar) for progressive, locally advanced or metastatic differentiated thyroid cancer in adults who have had radioactive iodine.

Result type

Technology appraisal guidance

Published

8 August 2018

Evidence-based recommendations on everolimus (Afinitor) for treating advanced breast cancer in adults after endocrine therapy.

Result type

Technology appraisal guidance

Published

21 December 2016

Evidence-based recommendations on relugolix (Orgovyx) for hormone-sensitive prostate cancer in adults.

Result type

Technology appraisal guidance

Published

14 August 2024

Evidence-based recommendations on pegylated liposomal irinotecan (Onivyde) for treating pancreatic cancer in adults.

Result type

Technology appraisal guidance

Published

26 April 2017

Evidence-based recommendations on brigatinib (Alunbrig) for treating anaplastic lymphoma kinase (ALK)-positive advanced non-small-cell lung cancer in adults who have already had crizotinib.

Result type

Technology appraisal guidance

Published

20 March 2019

Evidence-based recommendations on everolimus (Afinitor) for advanced renal cell carcinoma after previous treatment.

Result type

Technology appraisal guidance

Published

22 February 2017